Corresponding in vivo experiments have illustrated that pre-administration of exogenous Reelin protein into the ventricles prior to middle cerebral artery occlusion reduces cerebral infarct volume and promotes neuronal survival [13, 14]. This evidence concerns the gene RELN and brain infarction.